- PodcastEpisode 109Duration 36:23
Howie and Harlan are joined by Tina Loarte-Rodríguez, associate director, health equity measures, at Yale’s Center for Outcomes Research & Evaluation and the author of Latinas in Nursing: Stories of Determination, Inspiration, and Trust. And Howie and Harlan discuss the clinical and economic dimensions of two newly approved CRISPR-based treatments for sickle cell disease.
New Treatments for Sickle Cell Disease
- PodcastEpisode 108Duration 32:55
Howie and Harlan are joined by Tara Sanft, chief patient experience officer at Yale’s Smilow Cancer Hospital and director of the Survivorship Program at the Yale Cancer Center. Harlan reports on his study of patients with long-lasting symptoms after the COVID-19 vaccine; Howie reflects on the historic decline in cigarette smoking in the United States.
Patient Experience and Cancer Survivorship
The Decline in Smoking
- PodcastEpisode 107Duration 33:32
Howie and Harlan are joined by Stephanie Sudikoff, an expert on using simulation to train healthcare professionals, to discuss her new venture working to expand treatment for neonatal jaundice and how simulating procedures can assist in quality control and ongoing training. They also look at new developments in AI in radiology and the economics of a powerful treatment for inflammation.
AI and Radiology
Neonatal Jaundice and Medical Simulation
The Economics of Dupixent
- PodcastEpisode 106Duration 31:14
Howie and Harlan are joined by Jerold Mande, a nutrition expert who has served in the FDA, where he led the graphic design of the Nutrition Facts label, and the USDA. Harlan reports on promising new therapies for sickle cell disease, high cholesterol, and hypertension; Howie reflects on the Thanksgiving holiday and the contributions of former First Lady Rosalynn Carter, who died this week.
Food and Health
Rosalynn Carter and Doing Good
- PodcastEpisode 105Duration 31:57
Howie and Harlan review the results of a new study testing the effects of anti-obesity medications on cardiovascular health. Then they're joined by Yale's John Morton, a leading bariatric surgeon, to discuss the state of weight-loss surgery and its long-term impact on patients' lives.
- PodcastEpisode 104Duration 32:23
Howie and Harlan are joined by the New Yorker's Dhruv Khullar to talk about his life as a clinician, researcher, and journalist. Harlan looks at how direct-to-consumer healthcare companies like Hims & Hers Health are capitalizing on patients' reluctance to share sensitive issues with traditional providers; Howie reports on the health issues on the ballot in this week's election.
The Loss of Trust and the Rise of Hims & Hers Health
Health on the Ballot
- PodcastEpisode 103Duration 32:46
Howie and Harlan are joined by Melinda Pettigrew of the Yale School of Public Health to discuss the changes needed in the prescription and agriculture use of antibiotics to address the crisis of antimicrobial resistance. Harlan reports on a survey underlining the scale of medical misinformation among Americans; Howie discusses a new tool for the treatment of unhoused people.
Melinda Pettigrew and Antimicrobial Resistance
Treating the Unhoused
- PodcastEpisode 102Duration 34:31
Howie and Harlan discuss current issues in healthcare, including burnout at the hospital, the downsides to Medicare Advantage, and how AI is helping radiologists catch tiny blood clots.
COVID-19 and Vaccinations
Mental Health in Healthcare
Artificial Intelligence in Healthcare
What’s a Normal Temperature?
- PodcastEpisode 101Duration 42:26
Howie and Harlan are joined by health economist Katherine Baicker of the University of Chicago to discuss her career in academia and government, the landmark Oregon Health Insurance Experiment, and the optimal design for universal healthcare coverage. Harlan asks why life expectancy in the U.S. increasingly lags behind peer nations; Howie discusses the politics threatening the PEPFAR program, which has saved millions of lives around the world.
U.S. Life Expectancy
- PodcastEpisode 100Duration 32:27
In the 100th episode of Health & Veritas, Howie and Harlan are joined by Peter Salovey, the president of Yale University and a pioneering psychology scholar. They discuss Salovey’s tenure as president, which ends in 2024; the future of the newly independent Yale School of Public Health; and Salovey’s influential research on emotional intelligence.